Northway Biotech is a leading contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of biopharmaceuticals. The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing.
Our state-of-the-art facilities in the EU and US include more than 30 R&D labs for CLD, USP, DSP, and analytical development, as well as cGMP manufacturing. Whether mammalian cell culture or microbial processing is optimal for your product's development, our cGMP facilities are equipped with separate production units to support the development and manufacturing of your drug substance and aseptic drug product.
Northway Biotechpharma and Memo Therapeutics AG collaborate on the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody for the therapy of COVID-19Read More
Northway Biotechpharma, biologics CDMO, announces company brand name change to Northway BiotechRead More